Filing Flows › GoodRx Holdings (GDRX) › Net income
GoodRx Holdings (GDRX) net income by quarter
GoodRx Holdings' net income was $8.5M in Q2 2026 (second quarter 2026), +630% from Q1 2026. Over the last 7 quarters it ranged from $1.1M (Q3 2025) to $12.8M (Q2 2025).
| Quarter | Net income | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $8.5M | +630% | -34% |
| Q1 2026 | $1.2M | -78% | -89% |
| Q4 2025 | $5.4M | +385% | -20% |
| Q3 2025 | $1.1M | -91% | — |
| Q2 2025 | $12.8M | +16% | — |
| Q1 2025 | $11.1M | +64% | — |
| Q4 2024 | $6.7M | — | — |
Q2 2026 at a glance
GoodRx Holdings, Q2 2026: revenue $200M (-1% year over year), operating margin 11.8%, net earnings $8.5M, operating cash flow $80.8M. The chart follows the revenue to costs, profit and cash.
Questions
What is GoodRx Holdings' net income?
GoodRx Holdings' net income was $8.5M in Q2 2026 (second quarter 2026), +630% from Q1 2026.
How has GoodRx Holdings' net income changed?
Over the last 7 quarters it ranged from $1.1M (Q3 2025) to $12.8M (Q2 2025).